Does GLATIRAMER Cause Lipoatrophy? 218 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 218 reports of Lipoatrophy have been filed in association with GLATIRAMER (GLATIRAMER ACETATE). This represents 0.5% of all adverse event reports for GLATIRAMER.
218
Reports of Lipoatrophy with GLATIRAMER
0.5%
of all GLATIRAMER reports
0
Deaths
5
Hospitalizations
How Dangerous Is Lipoatrophy From GLATIRAMER?
Of the 218 reports, 5 (2.3%) required hospitalization.
Is Lipoatrophy Listed in the Official Label?
Yes, Lipoatrophy is listed as a known adverse reaction in the official FDA drug label for GLATIRAMER.
What Other Side Effects Does GLATIRAMER Cause?
Injection site pain (5,003)
Multiple sclerosis relapse (3,695)
Drug ineffective (3,321)
Injection site reaction (3,317)
Multiple sclerosis (2,596)
Injection site erythema (2,560)
Fatigue (2,408)
Dyspnoea (2,364)
Injection site mass (2,172)
Injection site swelling (1,836)
What Other Drugs Cause Lipoatrophy?
LAMIVUDINE (30)
FINASTERIDE (29)
ZIDOVUDINE (22)
RITONAVIR (18)
STAVUDINE (18)
TRIAMCINOLONE ACETONIDE (18)
MEDROXYPROGESTERONE\MEDROXYPROGESTERONE (16)
ATAZANAVIR (14)
TRIAMCINOLONE (14)
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES (13)
Which GLATIRAMER Alternatives Have Lower Lipoatrophy Risk?
GLATIRAMER vs GLECAPREVIR\PIBRENTASVIR
GLATIRAMER vs GLEEVEC
GLATIRAMER vs GLICLAZIDE
GLATIRAMER vs GLIMEPIRIDE
GLATIRAMER vs GLIMEPIRIDE\ROSIGLITAZONE